Mortality Control Program for Economically Productive Age Group in Tribal Area of Melghat.

NCT07436104 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 72564

Last updated 2026-02-27

No results posted yet for this study

Summary

Background: Age specific mortality rate (ASMR) of 16-60 years is very high in Indian tribal areas due to communicable and non-communicable diseases.

Objectives:

The primary objective is to reduce the ASMR in 16-60 years age group by at-least 30% from 16 tribal villages of Melghat. The secondary objectives are to reduce cause-specific mortality rates (CSMR) in 16-60 years age group because of diarrhoea, malaria, pneumonia, etc.

Design: Community-based, single-centered, parallel-arm, cluster randomised controlled trial.

Setting: 36 tribal villages/clusters (research phase: 2004-2015) and 44 new villages (replication phase: 2016-2022) were externally randomized by lottery method to intervention arm (IA) or control arm (CA).

Participants: All persons in age group of 16-60 years from inaccessible 80 tribal villages.

Interventions: Trained VHWs in IA, provided behaviour change communication, treatment and referral. Except principal investigator, other study staff and participants were double blinded.

Conditions

Interventions

COMBINATION_PRODUCT

Trained village health workers (VHWs) , provided treatment of HTN, diarrhoea, malaria, pneumonia, asthma and COPD by Amlodipine, ORS, Norfloxacin, Chloroquine, Azithromycin, salbutamol rotacaps

Unlike traditional vertical programs that focus on a single disease, this study utilizes Village Health Workers (VHWs) to manage a broad diseases spectrum in villages, ranging from chronic NCDs like Hypertension (Amlodipine) and COPD/Asthma (Salbutamol Rotacaps/Derriphylline) to acute infectious diseases like diarrhoea, malaria, pneumonia, requiring Norfloxacin, Chloroquine, and Azithromycin. Key Differentiators * Holistic Mortality Targeting: While most Cluster Randomized Controlled Trials (CRCTs) focus on maternal or child health, this study specifically targets the Adult Specific Mortality Rate (ASMR). * Operational Sustainability: We combined Behavior Change Communication (BCC) with an integrated treatment and referral algorithm, a factor rarely captured in other intervention studies. * Temporal Stability: The 18-year duration ensures the findings are not skewed by transient epidemics/ seasonal outbreaks, establishing a benchmark for scalable, long-term health system strengthening.

OTHER

Appropriate referral

The VHWs in control area provided appropriate referral.

Sponsors & Collaborators

  • Caring Friends, Mumbai

    collaborator UNKNOWN
  • Stitchting Geron, The Netherland

    collaborator UNKNOWN
  • Mastek Foundation

    collaborator UNKNOWN
  • Tribal Development Department, Government of India

    collaborator UNKNOWN
  • MAHAN Trust

    lead OTHER

Principal Investigators

  • Ashish R Satav, MBBS, MD · MAHAN Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-01-01
Primary Completion
2015-12-31
Completion
2023-08-31

Countries

  • India

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07436104 on ClinicalTrials.gov